Once-a-month HIV PrEP could be the future and replace daily pills
Truvada is one of the ARV drugs that are currently used as a daily pre-exposure prophylaxis, or PrEP. Image: 123RF/Alexander Raths Women who are at risk of HIV infection and are using HIV pre-exposure prophylaxis (PrEP) on a daily basis might in the near future have to use only one pill a month, if a trial conducted in SA and other parts of the world is successful. This week the efficacy study, which is led by the University of Washington, received a $122m grant from the B...
Connie Celum University Of Washington Melinda Gates Foundation Sub Saharan Africa Impower 22 Hiv Prep
Source: heraldlive.co.za